How effective is Dabrafenib?

Based on long-term follow-up of the Phase III trials of dabrafenibgatrimmetinib in metastatic melanoma, 4 years and 5 years were 37% and 34% respectively. The 5 year overall survival rate for complete response patients was 71%. For advanced cancer, patients taking dabrafenib can continue to take it as long as it is effective and the side effects are not too severe. To prevent melanoma skin cancer from coming back after surgery, patients need to take dabrafenib for up to 12 months. If you want to get more high-quality information, you can contact Yaode. Yade will do its best to learn more about high-quality overseas drugs for you.